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Glucose and insulin (GI) levels are associated with left ventricular mass (LVM) in insulin-
resistant individuals. Obesity and cardiovascular disease are associated and up to 60% of 
overweight or obese patients have hypertension (OH). Antihypertensive therapy (AD) have 
different effects on GI metabolism (GIM) and on LVM. To evaluate whether the effects of AD 
on LVM and on GIM are associated, we compared telmisartan (T) and aliskiren (A) on these 
parameters in a group of insulin-resistant 43 elderly OH, aged 68 ± 6 year, with a body mass 
index of 32.8 ± 5.0 kg/m2, free of coronary or valvular heart disease, with normal LV function, 
randomized to treatment with T (n = 22) or A (n = 21). Echocardiographic LVM corrected for 
height (LVM/height), GIM (3-h intravenous glucose tolerance test) and albuminuria (Al) were 
measured after 4–6 weeks of washout and 6 months of treatment. Baseline characteristics 
were similar in both groups. T and A effectively reduced blood pressure (BP) (from 149 ± 13/98 
± 4 to 127 ± 8/82 ± 6 mmHg and from 148 ± 9/98 ± 4 to 129 ± 9/82 ± 6 mmHg, respectively, p = 
0.002). T significantly worsened GIM parameters, fasting glucose levels (5.3 ± 0.9 to 6.0 ± 1.5 
mmol/l; p = 0.003), fasting insulin levels (121 ± 121 to 189 ± 228 pmol/l; p = 0.03), and most 
other relevant metabolic measures (p < 0.05 for all). A did not affect GIM. T did not affect 
LVM/height (p = 0.8), whereas A significantly reduced LVM/height (p = 0.04). Upon BP 
control, Al was markedly decreased in both group (p = 0.002). In the absence of weight loss, 
most patients required combined AD to control their BP, regardless of their body fat 
distribution pattern. Optimal target BP and normal Al were achieved in the group T as a 
whole and in both OH groups, while benefits to cardiac structure were of a smaller magnitude. 
In high-risk OH T provides significantly greater BP lowering vs. A throughout the 24-h dosing 
interval, particularly during the hazardous early morning hours. Therefore in elderly OH 
adequate and similar BP control was achieved with T and A; however, A but not T was 
associated with a more favorable GIM profile and led to a significant regression of LVM. 
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